These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2981928)
1. Impaired oxidative burst does not affect human monocyte tumoricidal activity. Chen AR; Koren HS J Immunol; 1985 Mar; 134(3):1909-13. PubMed ID: 2981928 [TBL] [Abstract][Full Text] [Related]
2. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst. Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242 [TBL] [Abstract][Full Text] [Related]
3. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors. Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease. Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897 [TBL] [Abstract][Full Text] [Related]
5. Characterization of hydrogen peroxide-potentiating factor, a lymphokine that increases the capacity of human monocytes and monocyte-like cell lines to produce hydrogen peroxide. Gately CL; Wahl SM; Oppenheim JJ J Immunol; 1983 Dec; 131(6):2853-8. PubMed ID: 6438232 [TBL] [Abstract][Full Text] [Related]
6. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F; Peri G; Villa A; Mantovani A J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624 [TBL] [Abstract][Full Text] [Related]
7. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929 [TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor. Chen AR; McKinnon KP; Koren HS J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966 [TBL] [Abstract][Full Text] [Related]
9. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. Martin JH; Edwards SW J Immunol; 1993 Apr; 150(8 Pt 1):3478-86. PubMed ID: 8385686 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. Katz P; Simone CB; Henkart PA; Fauci AS J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. Sampson-Johannes A; Carlino JA J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901 [TBL] [Abstract][Full Text] [Related]
13. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. Frey JR; Kamber M; Peck R Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569 [TBL] [Abstract][Full Text] [Related]
14. Halothane anesthesia decreases human monocyte hydrogen peroxide generation. Protection of monocytes by activation with gamma interferon. Stevenson GW; Hall S; Rudnick SJ; Alvord G; Rossio J; Urba W; Leventhal JB; Miller P; Seleny F; Stevenson HC Immunopharmacol Immunotoxicol; 1987; 9(4):489-510. PubMed ID: 3125239 [TBL] [Abstract][Full Text] [Related]
15. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes. Abrams SI; Brahmi Z J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820 [TBL] [Abstract][Full Text] [Related]
16. Role of oxygen in antibody-dependent cytotoxicity mediated by monocytes and neutrophils. Borregaard N; Kragballe K J Clin Invest; 1980 Oct; 66(4):676-83. PubMed ID: 6252248 [TBL] [Abstract][Full Text] [Related]
17. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. Hellstrand K; Asea A; Dahlgren C; Hermodsson S J Immunol; 1994 Dec; 153(11):4940-7. PubMed ID: 7963557 [TBL] [Abstract][Full Text] [Related]
18. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. Mavier P; Edgington TS J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594 [TBL] [Abstract][Full Text] [Related]
19. Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears. Dallegri F; Frumento G; Minervini F; Muttini P; Patrone F Exp Hematol; 1982 Nov; 10(10):859-66. PubMed ID: 6295791 [TBL] [Abstract][Full Text] [Related]